Pediatric Malignant Brain Tumor -Diffuse Intrinsic Pontine Glioma Clinical Trial
Official title:
Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children
Although DIPG is not curable, re-irradiation with a modest total dose and short treatment
time provides good palliation of symptoms, improves quality of life, delays disease
progression and has minimal and manageable toxicity.
Treatment plan:
At progression, full radiological and clinical documentation necessary including a
neurological exam by a neurologist will be done. Progressive patients will be referred to
radiotherapy.
Radiation guidelines:
30.6 Gray (Gy) will be applied in 1.8 to 2Gy fractions in conformal radiation to tumor bed.
Radiation will be done in standard accelerators and according to standard guidelines used in
treatment for all brain tumor patients.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment